Market Cap$25.79B
P/E29.42x
PEG Ratio1.27
Div yield1.35%
Beta0.89
LH Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)8.35%
Price vs S&P 500 (4W)0.38%
PEG Ratio1.27
VGM Score48.43
P/E Ratio (Annual)29.42x
Indicated Dividend Yield (Annual)1.35%
LH Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $4.77 | $4.99 | +4.65%(+$0.22) | |
| Q1 2026 | $4.12 | $4.25 | +3.26%(+$0.13) | |
| Q4 2025 | $3.94 | $4.07 | +3.25%(+$0.13) | |
| Q3 2025 | $4.14 | $4.18 | +1.01%(+$0.04) | |
| Q2 2025 | $4.16 | $4.35 | +4.47%(+$0.19) |
LH Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.14
4.18
4.11
4.11
Industry Peers — Health Services(30)
| Symbol | Value Score | Growth Score | Momentum Score | P/E Ratio (Annual) | Revenue Growth TTM (YoY) | Operating Margin (TTM) | ROE (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
LHLabcorp Holdings Inc. | C | D | B | 29.4x | 6.4% | 10.4% | 11.6% | $317.95 |
| NTRANatera, Inc. Common Stock | F | A | A | — | 37.8% | -10.7% | -11.7% | $393.44 |
| DGXQuest Diagnostics Inc. | C | D | B | 26.1x | 9.9% | 14.1% | 14.5% | $235.00 |
| GHGuardant Health, Inc. Common Stock | F | A | B | — | 42.7% | -40.2% | -246.6% | $158.60 |
| CAICaris Life Sciences, Inc. Common Stock | F | A | B | — | 38.5% | 12.7% | 18.8% | $30.56 |
| RDNTRadNet, Inc. Common Stock | D | C | C | 1779.3x | 18.9% | 3.0% | -1.9% | $68.80 |
| GRALGRAIL, Inc. Common Stock | D | B | B | — | 23.1% | -338.4% | -15.9% | $117.81 |
| BLLNBillionToOne, Inc. Class A Common Stock | F | F | C | 621.1x | — | 10.9% | 8.9% | $98.12 |
| VCYTVeracyte, Inc. | D | B | C | 52.2x | 17.3% | 19.6% | 8.6% | $43.12 |
| CDNACareDx, Inc. | D | B | A | 18.3x | 34.4% | 23.6% | 32.8% | $64.00 |
| CELCCelcuity Inc. Common Stock | — | — | D | — | — | — | -244.6% | $56.58 |
About Labcorp Holdings Inc.
Labcorp is one of the two largest independent clinical laboratory companies in the United States, commanding approximately 20% of the independent lab market. The company operates roughly 2,000 patient-service centers and offers a comprehensive suite of 5,000 clinical tests, from routine blood and urine analysis to advanced oncology and genomic testing.